Scientific Approach to Clinical Research and Practice

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/120

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:26 PM on 9/10/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

121 Terms

1
New cards

the engine of medicine. it drives the discovery of new drugs, new services, and new clinical strategies.

research

2
New cards

new clinic models, telepharmacy, collaborative care.

practice-based innovations

3
New cards

whether you're making new knowledge or just applying it, you must understand research ______________.

principles

4
New cards

research in the biological and medical sciences that aims to improve health.

biomedical research

5
New cards

curiosity-driven, understanding the "why" of biology.

basic research

6
New cards

solving practical problems with basic knowledge.

applied research

7
New cards

testing in humans.

clinical research

8
New cards

how drugs and pharmacy systems affect care.

pharmaceutical practice and policy research

9
New cards

systematic study of fundamental phenomena — the "pure science" tier.

basic research

10
New cards

which type of research: figuring out how sodium channels open/close in neurons (before we even think about seizures or AEDs). it's done in labs, often involving biology, physiology, biochemistry.

basic research

11
New cards

builds the foundation for applied research — applied scientists can't design new drugs without ________________ researchers first explaining the target.

basic

12
New cards

research with a specific, practical goal in mind.

applied research

13
New cards

if basic research discovers how a receptor works, _____________ research asks: "Can we make a drug to target it?"

applied

14
New cards

conducted in animals or other models before humans.

focus areas: pharmacology (drug effects), medicinal chemistry (drug design), and pharmaceutics (drug formulation/delivery).

applied research

15
New cards

the systematic application of knowledge to create new products (drugs, devices, methods).

drug development

16
New cards

creative, structured work to expand knowledge and turn it into useful applications.

research and development

17
New cards

research that directly involves humans or human tissue/behavior.

focus: understanding, preventing, diagnosing, treating, and curing diseases in people.

clinical research

18
New cards

studies mechanisms of disease, drug effects, new interventions.

patient-oriented research

19
New cards

looks at disease patterns, risk factors, health behaviors.

epidemiological and behavioral research

20
New cards

studies effectiveness/efficiency of care delivery (real-world practice).

health services research

21
New cards

the pharmacy lens on health services research. focuses on pharmaceuticals, pharmacy services, and pharmacy systems. multidisciplinary: pulls from clinical, behavioral, economic, organizational, and technological perspectives. examines cost, access, and quality of pharmaceutical care.

pharmaceutical practice and policy research

22
New cards

how drugs are used and their effects in populations.

pharmacoepidemiology

23
New cards

cost-effectiveness of therapies.

pharmacoeconomics

24
New cards

patient results from pharmacy interventions.

pharmaceutical outcomes research

25
New cards

innovation in pharmacy practice (e.g., collaborative MTM clinics, telepharmacy).

pharmacy practice-based research

26
New cards

this type of research creates the evidence base that justifies pharmacists' expanding role in healthcare. without it, we'd be stuck defending our value with anecdotes.

pharmaceutical practice and policy research

27
New cards

all about moving discoveries along the pipeline — from lab → humans → clinical settings → practice → populations.

translational research

28
New cards

lab discoveries → first human testing ("bench to bedside").

T1: translation to humans

29
New cards

patients → clinical guidelines (turning trial results into standard recommendations).

T2: translation to clinical settings

30
New cards

guidelines → everyday clinical practice (doctors, pharmacists, nurses actually using them).

T3: translation to practice

31
New cards

practice → populations (studying effectiveness at the community and public health level).

T4: translation to populations

32
New cards

head-to-head testing of different options to see which one actually works better (and for whom).

comparative effectiveness research

33
New cards

compares benefits vs harms of alternative methods for prevention, diagnosis, treatment, or care delivery. goal: optimize patient outcomes by making decisions based on real comparisons, not just "this drug works in theory."

comparative effectiveness research

34
New cards

evaluation of alternatives (Drug A vs Drug B, pill vs injection, telehealth vs in-person).

comparative effectiveness

35
New cards

as data grows, it's easier to directly compare therapies. there's a rising demand for treatment comparisons so clinicians can choose smarter. the real audience = decision-makers (providers, payers, policymakers) at both the individual (patient-level) and system (population-level).

example: should Medicaid cover Drug A or Drug B for diabetes? CER provides the evidence.

comparative effectiveness analysis

36
New cards

instead of focusing only on disease or drugs, it centers patients' voices and preferences. patients and caregivers are included in research → helping them make informed decisions.

patient centered outcomes research

37
New cards

funds this work in the U.S.

example: a patient with arthritis might care less about lab results and more about whether a new med lets them walk their dog without pain. that outcome is equally important.

the Patient-Centered Outcomes Research Institute

38
New cards

knowledge must be based on observation and experience (not vibes or authority).

empiricism

39
New cards

no bias — data collection, design, and analysis must be neutral.

objectivity

40
New cards

provides the framework to ask meaningful questions (why we think X might affect Y).

theory

41
New cards

protects human subjects, ensures moral responsibility, guided by IRBs and federal regulations.

ethics

42
New cards

select all that apply:

what are the four steps in the process of scientific inquiry?

1. pose a research question + hypothesis.

2. develop and implement a research plan.

3. collect and analyze data.

4. report findings.

43
New cards

good ________________ come from clinical practice, policy gaps, current issues, or theory.

research questions

44
New cards

a strong question has to pass the ________________:

feasible (can it realistically be studied?)

interesting/novel (does it add something new?)

ethical (safe, approved, protects subjects)

relevant (to pharmacy, medicine, or society).

FINER test

45
New cards

do you have funding, expertise, access to patients/data?

feasibility

46
New cards

does it contribute beyond what's already known?

novelty

47
New cards

governed by IRBs, must follow federal rules.

ethics

48
New cards

must matter to pharmacy practice and stakeholders (patients, providers, payers, policymakers).

relevance

49
New cards

how science moves from lab to lives:

translational research makes discoveries useful.

_____________________ shows which options are best.

PCOR ensures patients' voices shape care.

the scientific method and FINER criteria ensure research is solid, ethical, and impactful.

comparative effectiveness research

50
New cards

this framework is like a recipe for building a sharp, testable clinical research question.

PICOTS

51
New cards

kids, adults, elderly, or specific disease groups.

population

52
New cards

med, device, service, policy.

intervention

53
New cards

placebo, usual care, or another treatment.

comparator

54
New cards

economic (cost), clinical (mortality, morbidity), or humanistic (quality of life).

outcomes

55
New cards

short-, intermediate-, long-term.

timeline

56
New cards

outpatient, inpatient, community.

setting

57
New cards

instead of saying "does drug X work?" you'd ask:

"In elderly patients with hypertension (________________), does drug X (intervention) compared to drug Y (comparator) improve quality of life (outcome) over 12 months (timeline) in an outpatient setting (setting)?"

population

58
New cards

research often focuses on economical, clinical, and humanistic outcomes

ECHO

59
New cards

outcomes: costs of care (direct and indirect).

economic

60
New cards

outcomes: morbidity/mortality, safety, effectiveness.

clinical

61
New cards

outcomes: patient-reported quality of life, functional status.

humanistic

62
New cards

__________ for research: some outcomes are short-term (blood pressure drop after 4 weeks) vs long-term (reduced stroke risk over 10 years).

timeline

63
New cards

classification of research: just describing what is (prevalence of diabetes in Houston).

descriptive

64
New cards

classification of research: testing relationships between variables (does obesity increase diabetes risk?).

analytical

65
New cards

classification of research: specifying an expected relationship (new drug ↓ HbA1c more than standard care).

hypothesis-driven

66
New cards

usually rooted in existing theories and evidence.

example: pathophysiology of diabetes + pharmacology of GLP-1 agonists → semaglutide improves glycemic control and reduces weight.

the expected relationship is often based on biomedical or sociobehavioral theory.

hypotheses

67
New cards

blueprint for answering your question.

research design

68
New cards

strongest (randomized controlled trials, or RCTs). test causality directly.

experimental research design

69
New cards

weaker (cohort, cross-sectional). they don't control variables but show associations. useful for real-world data.

observational research design

70
New cards

gold standard research design, but costly and not always feasible.

randomized clinical trial

71
New cards

cohort or cross-sectional. give insight into real-world practice, but prone to bias/confounding.

observational study design

72
New cards

example of a study design:

retrospective study on immunotherapy duration in lung cancer.

population: NSCLC patients on immunotherapy.

exposure: stopping at 2 years vs continuing indefinitely.

outcome: survival.

design: _____________________

key finding: stopping at 2 years gave similar outcomes to indefinite continuation → saves cost, reduces unnecessary treatment.

cohort (observational)

73
New cards

PICOTS helps craft a strong research question.

ECHO outcomes make sure the question is clinically, economically, and humanistically relevant.

hypotheses guide the direction, grounded in biology and prior research.

study design determines the strength of evidence ( _____________ > observational).

ultimately, all of this is about creating useful, credible, patient-centered evidence.

randomized clinical trial

74
New cards

how you collect and measure data.

research methodology

75
New cards

collect new data (surveys, lab tests, interviews, clinical assessments).

primary methods

76
New cards

use existing data (medical records, insurance claims, Medicare data).

secondary methods

77
New cards

the toolbox for answering your research question with numbers.

statistics

78
New cards

summarize data (means, medians, modes).

descriptive statistics

79
New cards

test hypotheses, generalize findings (t-tests, ANOVA, regression, Cox models).

inferential statistics

80
New cards

reports (journal articles, posters, abstracts) communicate findings. all credible research is ___________________ (other experts critique it before publication).

peer-reviewed

81
New cards

typical structure = IMRD format:

introduction: background, rationale, objective.

methods: how study was done.

results: data + analysis.

__________________ : interpretation, implications, limitations

discussion

82
New cards

visual tool to show survival probability over time.

Kaplan-Meier survival curves

83
New cards

multivariable regression model for survival data.

Cox proportional-hazard model

84
New cards

methodology matters — design + data collection drive credibility.

___________________ turn raw data into meaningful results.

reports communicate findings in a structured way (IMRD).

example study in the slides shows how real-world secondary data can identify safety risks (and potentially shape prescribing guidelines).

statistics

85
New cards

using the best scientific evidence to guide healthcare decisions for both individuals and populations.

evidence based medicine

86
New cards

goal of ________________ research: provide evidence that improves health and functioning.

clinical

87
New cards

delivering care that improves outcomes and aligns with professional knowledge.

quality in healthcare

88
New cards

select all that apply:

what are the six qualities of good healthcare?

1. safe

2. effective

3. patient-centered

4. timely

5. efficient

6. equitable

89
New cards

avoids harm.

safe

90
New cards

treatments should actually benefit patients.

effective

91
New cards

respects individual preferences and values.

patient-centered

92
New cards

doesn't delay needed care.

timely

93
New cards

avoids waste of resources.

efficient

94
New cards

no discrimination—care should not vary by race, gender, income, etc.

equitable

95
New cards

__________________ drives EBM. without good research, you're just guessing.

research evidence is the backbone—everything else flows from it.

goal: use relevant evidence to deliver highest quality patient care.

science

96
New cards

select all that apply:

what are the four steps in EBM?

1. ask an answerable question

2. find evidence

3. appraise evidence critically

4. apply to practice

97
New cards

this structure forces you to ask specific, testable questions. example: "in older adults with dementia and OAB, are selective antimuscarinics safer than non-selective ones?"

PICO method

98
New cards

the PICO method:

P = __________________

I = intervention

C = comparator

O = outcome

patient/population

99
New cards

are the study methods sound? did they avoid bias?

internal validity

100
New cards

can the findings apply to my patients, or was the study population too different?

external validity